On this episode of Stock Movers: - On Holding (ONON) is higher after it signed Kylian Mbappé as a partner in developing football products and representing the brand. The move marks On mounting a bold challenge to Nike and Adidas’ dominance of the sport. - Xenon Pharmaceuticals (XENE) is in a steep decline after it voluntarily halted a trial enrollment of azetukalner, which treats depression and bipolar, after studies showed adverse events. - Netflix (NFLX) shares are lower after Wells Fargo dow
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.